Institutional Ownership
Pharmacyte Biotech Inc
CUSIP 71715X203COM NEWPMCBQ1 2026
13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
30
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
6 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Mitchell P. Kopin | 13G/A | 5.0% | 532.3K | SEC |
| 2 | Feb 13, 2025 | Ayrton Capital LLC | 13G/A | 9.9% | 774.1K | SEC |
| 3 | Feb 14, 2024 | Ayrton Capital LLC | 13G | 9.9% | 956.2K | SEC |
| 4 | May 19, 2023 | Ayrton Capital LLC | 13G | 10.0% | 1.75M | SEC |
| 5 | Feb 14, 2023 | Shay Capital LLC | 13G/A | — | — | SEC |
| 6 | Oct 20, 2022 | Shay Capital LLC | 13G | 5.0% | 1.04M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Citadel Advisors LLC | 359.5K | $239.2K |
| 2 | Geode Capital Management, LLC | 195.7K | $130.2K |
| 3 | Renaissance Technologies LLC | 56.5K | $37.6K |
| 4 | Xtx Topco Ltd | 52.4K | $34.8K |
| 5 | Northern Trust Corp | 35.6K | $23.7K |
| 6 | Schonfeld Strategic Advisors LLC | 27.0K | $18.0K |
| 7 | Equitec Proprietary Markets, LLC | 22.2K | $14.8K |
| 8 | Simplex Trading, LLC | 19.9K | $13.3K |
| 9 | Two Sigma Securities, LLC | 16.4K | $10.9K |
| 10 | Jane Street Group, LLC | 11.5K | $7.7K |